云南“药王”为两个90后女儿分股份！市值1.57亿元

Core Viewpoint - The article discusses the planned share transfer by the controlling shareholder of Yixin Tang Pharmaceutical Group, which is a family internal transfer aimed at asset planning without affecting the company's control or governance structure [3][7]. Group 1: Share Transfer Details - On November 6, Yixin Tang announced that its chairman and controlling shareholder, Ruan Hongxian, plans to transfer up to 5.856 million shares (1% of total share capital) to each of his daughters, Ruan Shengxiang and Ruan Aixiang, through block trading within three months after fifteen trading days from the announcement [3][5]. - Ruan Hongxian held 31.74% of Yixin Tang's shares before the transfer, and the total market value of the company is approximately 7.9 billion yuan, making the estimated value of the transferred shares around 78 million yuan, totaling approximately 157 million yuan for both transfers [5]. Group 2: Company Background - Yixin Tang Pharmaceutical Group was founded in 1981 and established the "Yixin Tang" retail pharmacy chain in 2001, currently operating 8,990 stores across ten provinces and cities in China [8]. - The company was listed on the Shenzhen Stock Exchange on July 2, 2014, becoming a publicly traded retail pharmacy chain [8]. Group 3: Family and Business Dynamics - Ruan Hongxian and Liu Qiong co-founded the predecessor of Yixin Tang in 1987, and their wealth was recognized in the 2016 Hurun Rich List, where they ranked second in Yunnan with a fortune of 6.7 billion yuan [10]. - Following their divorce in 2017, Ruan Hongxian and Liu Qiong divided their shares according to their pre-divorce holdings, with Ruan holding 33.75% and Liu holding 18.37% of the company [10][11]. - Ruan Shengxiang and Ruan Aixiang, both in their 20s, are involved in the family business, with Ruan Shengxiang serving as vice chairman of the Saint Love Traditional Chinese Medicine Group and Ruan Aixiang appointed as vice president of Yixin Tang [15][16].